News of Note—Novavax, Walter Reed and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Novavax has enrolled the first participants in a phase 2 study of its NanoFlu in older adults. Release

> The Walter Reed Army Institute of Research signed a deal with Enesi Pharma for the development of a needle-free Shigella vaccine. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> The Biomedical Advanced Research and Development Authority awarded Altimmune an additional $2.5 million to support work on its anthrax vaccine candidate NasoShield. Release

> LineaRx, a subsidiary of Applied DNA, signed on with Takis and Evvivax to developed DNA-based cancer vaccines. Release

Read more on